Bone Health News and Research

RSS

Covid deaths plummet in England, but dementia and heart disease remain a concern

New Government figures show a higher than average number of deaths last month. Dementia was the biggest killer in England and heart disease in Wales.

1 Jul 2023

Testing whether osteoporosis drugs plus “bone-loading” exercises can help older adults to safely lose weight

A $7 million study beginning this summer at Wake Forest University and Wake Forest University School of Medicine will help determine whether a combination of resistance training plus bone-strengthening exercises and/or osteoporosis medication use can help older adults safely lose weight without sacrificing bone mass.

30 Jun 2023

From deserts to desserts: cacti components for new functional foods

Researchers described promising features of using cactus in the food sector, addressing the plant's functional, nutritional, and sustainable qualities.

29 Jun 2023

Light or moderate alcohol consumption does not protect against endocrine conditions

People who have just one or two drinks per day are not protected against endocrine conditions such as obesity and type 2 diabetes, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

27 Jun 2023

Social isolation negatively impacts bone health in mice

Social isolation may negatively impact bone health, suggests a study conducted in mice being presented Sunday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

18 Jun 2023

Transgender adolescents rarely chose to discontinue gender-affirming hormone therapy, finds study

A three-year-long retrospective cohort study of a single Atlanta hospital's patient population found transgender and gender-diverse teenagers rarely chose to discontinue gender-affirming hormone therapy, according to a study being presented Sunday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

18 Jun 2023

Testosterone therapy reduces gender dysphoria, depression and suicidality in trans adults

Receiving rapid access to testosterone therapy reduced feelings of gender dysphoria and led to a clinically significant reduction in depression as well as a 50% reduction in suicidality among transgender and gender diverse adults, according to research being presented Sunday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

18 Jun 2023

Radioactive iodine or surgery linked to decreased mortality risk in patients with hyperthyroidism

Hyperthyroidism treatment like radioactive iodine or surgery was associated with a decreased risk for death, according to research being presented Saturday at ENDO 2023, the Endocrine Society's annual meeting in Chicago.

18 Jun 2023

Closed-loop system appears to be safe and superior to usual care in controlling glucose in children with type 1 diabetes

Closed-loop insulin delivery systems improve glucose control in children with type 1 diabetes without causing adverse effects, according to a study presented Saturday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

18 Jun 2023

Improving access to transgender-friendly health care can help decrease the burden on ERs

Transgender people who come to the emergency room for care tend to be sicker than cisgender people who are otherwise similar to them and are much more likely to be admitted to the hospital once they visit the ER, according to a study being presented Saturday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

18 Jun 2023

Employees with obesity may have lower work productivity compared to people with normal weight

People with obesity may have lower work productivity due to increased risk of illness, contributing to increased costs for employers, according to industry-supported research being presented Saturday at ENDO 2023, the Endocrine Society's annual meeting, in Chicago, Ill.

18 Jun 2023

Injectable osteoporosis drug can be safely administered orally using a novel 'robotic pill'

A proven and effective medication for osteoporosis, which is currently only available as an injection, can be administered orally using a novel "robotic pill," according to a study presented Saturday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

18 Jun 2023

Study: Metabolic-associated fatty liver disease is increasing among U.S. adults

The percent of metabolic associated fatty liver disease (MAFLD), the leading global cause of liver disease, is increasing in U.S. adults, according to a study presented Friday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

17 Jun 2023

Study finds increase in number of hypothyroidism patients receiving treatment other than levothyroxine

The use of thyroid hormones other than the commonly prescribed hormone medicine levothyroxine to treat hypothyroidism, or underactive thyroid, is increasing, according to a study being presented Friday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

16 Jun 2023

Endocrine Society's new Scientific Statement focuses on endocrine-related changes and aging

A new Scientific Statement released today by the Endocrine Society highlights the differences between aspects of aging that are normal and sometimes over-treated, and those such as menopausal symptoms and osteoporosis that can be treated and deserve more attention.

16 Jun 2023

Adverse cognitive effects linked to endocrine-disrupting chemicals may pass down through generations

Adverse cognitive effects linked to polychlorinated biphenyls (PCBs) exposure, a type of endocrine-disrupting chemical (EDC), have the potential to be passed down through generations, according to an animal study being presented Thursday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2023

Exposure to dioxins can negatively impact thyroid function

Exposure to dioxins can negatively impact thyroid function, according to a study presented Thursday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2023

Study: Some breast cancer drugs may lessen the effect of weight loss medications

Breast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presented Friday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2023

Study offers a new perspective on the reproductive toxicity of phthalates

Prenatal exposure to chemicals called phthalates, which are used in hundreds of products, may lead to hormonal changes in females that could affect their future fertility, suggests a study in mice being presented Thursday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2023

BMI not a complete measure of metabolic health, research shows

Body mass index (BMI) is not a complete measure of metabolic health, and a high proportion of U.S. adults with normal BMI still have obesity, according to research being presented Friday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2023

Bone Health News and Research

Covid deaths plummet in England, but dementia and heart disease remain a concern

Testing whether osteoporosis drugs plus “bone-loading” exercises can help older adults to safely lose weight

From deserts to desserts: cacti components for new functional foods

Light or moderate alcohol consumption does not protect against endocrine conditions

Social isolation negatively impacts bone health in mice

Transgender adolescents rarely chose to discontinue gender-affirming hormone therapy, finds study

Testosterone therapy reduces gender dysphoria, depression and suicidality in trans adults

Radioactive iodine or surgery linked to decreased mortality risk in patients with hyperthyroidism

Closed-loop system appears to be safe and superior to usual care in controlling glucose in children with type 1 diabetes

Improving access to transgender-friendly health care can help decrease the burden on ERs

Employees with obesity may have lower work productivity compared to people with normal weight

Injectable osteoporosis drug can be safely administered orally using a novel 'robotic pill'

Study: Metabolic-associated fatty liver disease is increasing among U.S. adults

Study finds increase in number of hypothyroidism patients receiving treatment other than levothyroxine

Endocrine Society's new Scientific Statement focuses on endocrine-related changes and aging

Adverse cognitive effects linked to endocrine-disrupting chemicals may pass down through generations

Exposure to dioxins can negatively impact thyroid function

Study: Some breast cancer drugs may lessen the effect of weight loss medications

Study offers a new perspective on the reproductive toxicity of phthalates

BMI not a complete measure of metabolic health, research shows

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News